Galafold

Chemical Namemigalastat
Dosage FormCapsules (oral; 123 mg)
Drug ClassMiscellaneous
SystemDigestive, Urinary, Cardiovascular, Skin
CompanyAmicus Therapeutics
Approval Year2018

Indication

  • To treat Fabry disease in adults with an amenable galactosidase alpha gene.
Last updated on 11/2/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Galafold (Migalastat) Prescribing Information 2018Amicus Therapeutics, Cranbury, NJ
Document TitleYearSource
Canadian Fabry disease treatment guidelines 2018. 2019Garrod Association